» Articles » PMID: 316807

Clonal Analysis of the Action of GM-CSF on the Proliferation and Differentiation of Myelomonocytic Leukemic Cells

Overview
Journal Int J Cancer
Specialty Oncology
Date 1979 Nov 15
PMID 316807
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

With 214 subclones of the BALB/c myelomonocytic leukemia WEHI-3B, the granulocyte-macrophage colony-stimulating factor (GM-CSF) in impure or purified form, consistently increased the proportion of colonies exhibiting partial or complete differentiation in agar cultures. GM-CSF also increased colony size and content of daughter colony-forming cells. Serial recloning of WEHI-3B colonies in the presence of GM-CSF showed that when colonies differentiated completely, self-replication of the colony-forming cell was suppressed (clonal extinction). However, WEHI-3B cells exhibited clonal instability and even in the continuous presence of GM-CSF many colony-forming cells still generated cells able to form undifferentiated colonies. It appears unlikely that GM-CSF can completely suppress the progressive proliferation of a myeloid leukemic population of the WEHI-3B type.

Citing Articles

Expression of leukemia inhibitory factor in craniopharyngioma.

Tran A, Kovacs K, Stefaneanu L, Kontogeorgos G, Scheithauer B, Melmed S Endocr Pathol. 2016; 10(2):103-8.

PMID: 27519214 DOI: 10.1007/BF02739822.


Is there a role for differentiating therapy in non-APL AML?.

Koeffler H Best Pract Res Clin Haematol. 2010; 23(4):503-8.

PMID: 21130414 PMC: 5884682. DOI: 10.1016/j.beha.2010.09.014.


The discovery of the first human retrovirus: HTLV-1 and HTLV-2.

Gallo R Retrovirology. 2005; 2:17.

PMID: 15743526 PMC: 555587. DOI: 10.1186/1742-4690-2-17.


Expression of leukemia inhibitory factor in human pituitary adenomas: a morphologic and immunocytochemical study.

Kontogeorgos G, Patralexis H, Tran A, Kovacs K, Melmed S Pituitary. 2000; 2(4):245-51.

PMID: 11081145 DOI: 10.1023/a:1009917731493.


Concanavalin A acceptor glycoproteins: a new type of marker for the classification of tumour cells.

Koch G, Smith M Br J Cancer. 1983; 47(4):527-36.

PMID: 6849797 PMC: 2011341. DOI: 10.1038/bjc.1983.83.